Showing results (391-400 of 632) with videos related to

Sort By:
Pageof 64
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|June 24, 2010
Observational study comparing intranasal mometasone furoate with oral antihistamines for rhinitis and asthmaDavid Price, Linda Kemp, Erika Sims, et al.
BMJ Open|September 11, 2019
Cohort profile: the Canadian coordination and activity tracking in children (CATCH) longitudinal cohortJohn Cairney, Scott Veldhuizen, M Christine Rodriguez, et al.
Annals of the American Thoracic Society|February 25, 2014
Complementing the randomized controlled trial evidence base. Evolution not revolutionDavid Price, Eric D Bateman, Alison Chisholm, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|May 17, 2006
International Primary Care Respiratory Group (IPCRG) Guidelines: management of allergic rhinitisDavid Price, Christine Bond, Jacques Bouchard, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational studyLinda Kemp, John Haughney, Neil Barnes, et al.
Journal of Asthma and Allergy|June 24, 2011
Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRDDavid Price, John Haughney, Erika Sims, et al.
JMIR Formative Research|April 11, 2022
Lessons Learned Through Two Phases of Developing and Implementing a Technology Supporting Integrated Care: Case StudyStephanie Di Pelino, Larkin Lamarche, Tracey Carr, et al.
NPJ Primary Care Respiratory Medicine|June 21, 2017
Erratum: Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: a real-world studyKevin Gruffydd-Jones, Guy Brusselle, Rupert Jones, et al.
Advances in Medical Education and Practice|June 8, 2013
Interprofessional Resource Centre: a knowledge translation strategyChristine Patterson, Julie Vohra, David Price, et al.
Chronic Respiratory Disease|February 1, 2021
Patient perceptions of the re-usable Respimatt® Soft Mist™ inhaler in current users and those switching to the device: A real-world, non-interventional COPD studyMichael Dreher, David Price, Asparuh Gardev, et al.
Pageof 64